Contineum Therapeutics (CTNM) Shares Outstanding (2023 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Shares Outstanding (Entity) of $37.6 million for Q2 2026, up 45.11% year-over-year from $25.9 million in Q2 2025, and up 0.61% quarter-over-quarter from $37.4 million in Q1 2026.
Contineum Therapeutics (CTNM) Shares Outstanding (2023 - 2026) Analysis & Trends
Contineum Therapeutics' Shares Outstanding (Entity) history runs 4 years deep, the most recent figure standing at $37.6 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 45.11% year-over-year to $37.6 million; the TTM figure through Jun 2026 stood at $37.6 million (up 45.11% YoY), while the FY2025 annual figure was $27.7 million, up 43.14% from the prior year.
- Shares Outstanding (Entity) for Q2 2026 stood at $37.6 million, up from $37.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $37.6 million in Q2 2026, with the low at $2.3 million in Q1 2023.
- The 4-year median for Shares Outstanding (Entity) is $25.7 million (2024), against an average of $20.0 million.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) soared 1020.66% in 2024, then climbed 0.76% in 2025.
- Contineum Therapeutics' Shares Outstanding (Entity) stood at $2.3 million in 2023, then jumped by 736.66% to $19.4 million in 2024, then jumped by 43.14% to $27.7 million in 2025, then surged by 35.78% to $37.6 million in 2026.
- Business Quant data shows CTNM's Shares Outstanding (Entity) at $37.6 million in Q2 2026, $37.4 million in Q1 2026, and $27.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 37.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 37.47 Mn |
| Mar 31, 2026 | 37.34 Mn |
| Dec 31, 2025 | 27.70 Mn |
| Sep 30, 2025 | 28.12 Mn |
| Jun 30, 2025 | 25.90 Mn |
| Mar 31, 2025 | 25.87 Mn |
| Dec 31, 2024 | 19.35 Mn |
| Sep 30, 2024 | 25.73 Mn |
| Jun 30, 2024 | 23.36 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | 18.08 Mn |
| Jun 30, 2023 | 2.30 Mn |
| Mar 31, 2023 | 2.28 Mn |